His primary scientific interests are in Internal medicine, Risk factor, Factor V Leiden, Venous thrombosis and Gastroenterology. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Surgery. His Factor V Leiden research is multidisciplinary, incorporating perspectives in Protein C, Thrombophilia and Factor V.
Pieter H. Reitsma has included themes like Asymptomatic, Activated protein C resistance, Immunology and Protein C deficiency in his Protein C study. His study in Factor V is interdisciplinary in nature, drawing from both Prothrombin G20210A and Allele frequency. His Venous thrombosis study incorporates themes from Relative risk and Pulmonary embolism.
Internal medicine, Molecular biology, Immunology, Genetics and Gene are his primary areas of study. His Internal medicine research includes elements of Gastroenterology, Endocrinology and Surgery. His work is dedicated to discovering how Molecular biology, Binding site are connected with Transactivation and other disciplines.
His Immunology research is multidisciplinary, relying on both Protein C and Tissue factor. In Protein C, Pieter H. Reitsma works on issues like Factor V Leiden, which are connected to Thrombophilia. His studies in Venous thrombosis integrate themes in fields like Single-nucleotide polymorphism and Case-control study, Pathology.
Pieter H. Reitsma mainly investigates Internal medicine, Venous thrombosis, Immunology, Thrombosis and Endocrinology. His work deals with themes such as Gastroenterology, Surgery and Genotype, which intersect with Internal medicine. The various areas that Pieter H. Reitsma examines in his Venous thrombosis study include Genetics, Gene, Coagulopathy, Hematology and Single-nucleotide polymorphism.
His studies deal with areas such as Disseminated intravascular coagulation, Protein C, Gene expression profiling and Tissue factor as well as Immunology. His work deals with themes such as Fibrinogen, Vascular disease and Pathology, which intersect with Thrombosis. Pieter H. Reitsma usually deals with Thrombophilia and limits it to topics linked to Knockout mouse and Factor V Leiden.
Pieter H. Reitsma mostly deals with Immunology, Internal medicine, Tissue factor, Protein C and Sepsis. His studies in Internal medicine integrate themes in fields like Gastroenterology and SNP. Pieter H. Reitsma combines subjects such as Case-control study, Allele frequency, Vascular disease, Factor V Leiden and Single-nucleotide polymorphism with his study of Gastroenterology.
His Tissue factor research incorporates elements of Tumor progression, Cancer research, Protein S and Thromboplastin. His Protein C research is multidisciplinary, relying on both Antithrombin, Gene knockdown, Fibrinogen, Gene silencing and Venous thrombosis. Pieter H. Reitsma interconnects Haplotype, Genotype, Factor V and Genetic variation in the investigation of issues within Venous thrombosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina;Bobby P. C. Koeleman;Ted Koster;Frits R. Rosendaal.
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.
Swibertus R. Poort;Frits R. Rosendaal;Pieter H. Reitsma;Rogier M. Bertina.
INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR V LEIDEN MUTATION
Jan P. Vandenbroucke;Ted Koster;Ernest Briet;Pieter H. Reitsma.
The Lancet (1994)
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
M. Den Heijer;T. Koster;H. J. Blom;G. M. J. Bos.
The New England Journal of Medicine (1996)
Geographic Distribution of the 20210 G to A Prothrombin Variant
F.R. Rosendaal;Catharina Jacoba Maria Doggen;A. Zivelin;V.R. Arruda.
Thrombosis and Haemostasis (1998)
NEW FUNDAMENTALS IN HEMOSTASIS
Henri H. Versteeg;Johan W. M. Heemskerk;Marcel Levi;Pieter H. Reitsma.
Physiological Reviews (2013)
Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.
Bobby P.C. Koeleman;Pieter H. Reitsma;C.F. Allaart;Rogier M. Bertina.
HIGH PLASMA CONCENTRATION OF FACTOR VIIIC IS A MAJOR RISK FACTOR FOR VENOUS THROMBOEMBOLISM
R. A. Kraaijenhagen;P. S. In't Anker;M. M. W. Koopman;P. H. Reitsma.
Thrombosis and Haemostasis (2000)
Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite.
P. H. Reitsma;P. G. Rothberg;S. M. Astrin;J. Trial.
Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3.
Zvi Bar-Shavit;Steven L. Teitelbaum;Pieter Reitsma;Ann Hall.
Proceedings of the National Academy of Sciences of the United States of America (1983)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: